Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.16 - $100.0 $21,733 - $13.6 Million
-135,833 Reduced 7.68%
1,632,769 $250,000
Q2 2022

Aug 12, 2022

SELL
$0.2 - $0.5 $297,760 - $744,401
-1,488,802 Reduced 45.71%
1,768,602 $732,000
Q1 2022

May 13, 2022

BUY
$0.41 - $0.63 $100,280 - $154,089
244,587 Added 8.12%
3,257,404 $1.79 Million
Q4 2021

Feb 11, 2022

SELL
$0.57 - $1.29 $8,993 - $20,353
-15,778 Reduced 0.52%
3,012,817 $1.75 Million
Q3 2021

Nov 12, 2021

BUY
$1.11 - $1.7 $340,604 - $521,646
306,851 Added 11.27%
3,028,595 $3.73 Million
Q2 2021

Aug 13, 2021

BUY
$1.46 - $2.25 $1.91 Million - $2.95 Million
1,311,611 Added 93.01%
2,721,744 $4.6 Million
Q1 2021

May 12, 2021

BUY
$1.77 - $2.93 $485,813 - $804,200
274,471 Added 24.17%
1,410,133 $2.52 Million
Q4 2020

Feb 12, 2021

BUY
$2.13 - $3.26 $213,183 - $326,280
100,086 Added 9.66%
1,135,662 $2.43 Million
Q3 2020

Nov 13, 2020

BUY
$1.53 - $3.13 $529,485 - $1.08 Million
346,069 Added 50.19%
1,035,576 $3.1 Million
Q2 2020

Aug 13, 2020

BUY
$0.48 - $1.75 $16,737 - $61,022
34,870 Added 5.33%
689,507 $1.03 Million
Q1 2020

May 14, 2020

SELL
$0.56 - $0.97 $7,759 - $13,441
-13,857 Reduced 2.07%
654,637 $371,000
Q2 2019

Aug 14, 2019

BUY
$0.94 - $1.6 $25,891 - $44,070
27,544 Added 4.3%
668,494 $688,000
Q1 2019

May 14, 2019

BUY
$0.51 - $1.88 $83,610 - $308,212
163,943 Added 34.37%
640,950 $999,000
Q4 2018

Feb 13, 2019

BUY
$0.39 - $3.47 $52,068 - $463,279
133,510 Added 38.87%
477,007 $205,000
Q3 2018

Nov 13, 2018

SELL
$1.39 - $2.25 $1,695 - $2,745
-1,220 Reduced 0.35%
343,497 $728,000
Q2 2018

Aug 14, 2018

SELL
$1.44 - $2.24 $98,696 - $153,527
-68,539 Reduced 16.59%
344,717 $496,000
Q1 2018

May 15, 2018

BUY
$1.51 - $2.06 $16,525 - $22,544
10,944 Added 2.72%
413,256 $677,000
Q4 2017

Feb 13, 2018

SELL
$1.4 - $2.6 $29,426 - $54,649
-21,019 Reduced 4.97%
402,312 $643,000
Q3 2017

Nov 14, 2017

SELL
$2.22 - $2.79 $40,659 - $51,098
-18,315 Reduced 4.15%
423,331 $1.08 Million
Q2 2017

Aug 14, 2017

BUY
N/A
441,646
441,646 $1.02 Million

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.